hydromorphone has been researched along with oxycodone in 100 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (4.00) | 18.7374 |
| 1990's | 6 (6.00) | 18.2507 |
| 2000's | 21 (21.00) | 29.6817 |
| 2010's | 50 (50.00) | 24.3611 |
| 2020's | 19 (19.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Ennis, M; Lorenz, W; Nehring, E; Schneider, C | 1 |
| Ciancio, SG | 1 |
| Foley, KM; Houde, RW; Inturrisi, CE; Moulin, DE; Nip, TJ; Reidenberg, B; Wallenstein, S; Weinberg, DS | 1 |
| Chi, CJ; Guo, YM; Liu, MQ; Zhu, CL | 1 |
| Dietzen, DJ; Koenig, J; Turk, J | 1 |
| Babul, N; Hagen, NA | 1 |
| Manfredi, B; Mantegazza, P; Panerai, AE; Sacerdote, P | 1 |
| Bohrer, A; Koenig, J; Nowatzke, W; Saunders, A; Turk, J; Zeng, J | 1 |
| Dahl, JL; Gilson, AM; Joranson, DE; Ryan, KM | 1 |
| Arcuri, E; Centulio, F; Ciocca, F; D'Angiolino, G; Ginobbi, P; Marcelli, ME; Pelagalli, L; Tirelli, W | 1 |
| Casas, JR; Cherny, N; Conno, F; Hanks, GW; Hanna, M; Kalso, E; McQuay, HJ; Mercadante, S; Meynadier, J; Poulain, P; Radbruch, L; Ripamonti, C; Sawe, J; Twycross, RG; Ventafridda, V | 1 |
| Kalso, E | 1 |
| Jones, J; Moore, C; Tomlinson, K | 1 |
| Ashby, M; Good, P; Goodchild, C; Jackson, K; Tullio, F | 1 |
| Hanks, GW; Reid, C | 1 |
| Carroll, PJ; Dalton, DR; Wilson, ML | 1 |
| Lindena, G; Müller-Busch, HC; Tietze, K; Woskanjan, S | 1 |
| Chelly, JE; Lin, HM | 1 |
| Giampetro, DM; Vorobeychik, Y | 1 |
| Bozkaya, D; Caro, JJ; Dubois, D; Fleischmann, J; Sabatowski, R; Ward, A | 1 |
| Hale, M; Khanna, S; Thipphawong, J; Tudor, IC | 1 |
| Friedrichsdorf, SJ; Kang, TI | 1 |
| Faugno, D; Gaensslen, RE; Greene, P; Haner, B; Juhascik, MP; Ledray, L; Lindner, A; Negrusz, A | 1 |
| Bruera, E; Hanson, J; Pereira, J; Tarumi, Y; Watanabe, S | 1 |
| Güttler, K; Sabatowski, R | 1 |
| Holtman, JR; Lofwall, MR; Nuzzo, PA; Walsh, SL | 1 |
| Bailey, JE; Campagna, E; Dart, RC | 1 |
| Bailey, FA; Burgio, KL; Durham, RM; Ferguson, L; Goode, PS; Redden, DT; Williams, BR; Woodby, LL | 1 |
| Dahn, T; Gunn, J; Kriger, S; Terrell, AR | 1 |
| Gingras, M; Laberge, MH; Lefebvre, M | 1 |
| Gould, EM; Peniston, JH; Xiang, Q | 1 |
| Alford, I; Shan, X; Tiscione, NB; Yeatman, DT | 1 |
| Ewan, EE; Martin, TJ | 1 |
| Kahan, M; Mailis-Gagnon, A; Srivastava, A; Wilson, L | 1 |
| Janecek, E; Kahan, M; Resnick, A; Sheehan, C; Srivastava, A; Wenghofer, EF; Wilson, L | 1 |
| French, D; Lynch, K; Wu, A | 1 |
| Binsfeld, H; Richarz, U; Sabatowski, R; Szczepanski, L; Waechter, S | 1 |
| Glaeske, G; Hoffmann, F; Windt, R | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Boche, R; Englbrecht, JS; Pogatzki-Zahn, EM; Pöpping, D; Zahn, PK | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Addante, RA; Charlson, MD; Michelson, JD | 1 |
| Goon, AK; Goytizolo, EA; Kahn, RL; Kim, DH; Lee, YY; Lin, Y; Ma, Y; Maalouf, DB; Manohar, A; Patt, ML; Yadeau, JT | 1 |
| Mazer-Amirshahi, M; Mullins, PM; Pines, JM; Rasooly, I; van den Anker, J | 1 |
| Black, RA; Butler, SF; Chilcoat, HD; Coplan, PM; McNaughton, EC; Weber, SE | 1 |
| Han, J; Hou, Y; Richards, HM; Shen, W; Yu, L; Yu, S | 1 |
| Galanie, S; Smolke, CD; Thodey, K | 1 |
| Ihenetu, K; Na, S; Rosano, TG; Swift, TA; Wood, M | 1 |
| Bernardy, K; Häuser, W; Maier, C | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Csikós, Á; Kullmann, T; Pintér, T; Sipőcz, I | 1 |
| Bafuma, PJ; Nandi, A; Weisberg, M | 1 |
| ElSohly, MA; Godfrey, M; Gul, SW; Gul, W; Stamper, B | 1 |
| Darragh, A; Lee, LA; Marinova, M; Mastrianni, KR; Melendez, C; Ryan, E; Sitasuwan, P | 1 |
| Bao, YJ; Hou, W; Hua, BJ; Knaggs, R; Kong, XY; Xia, J; Yang, L | 1 |
| Dasgupta, A; Dixon, RB | 1 |
| Hernandez, NM; Parry, JA; Taunton, MJ | 1 |
| de Rooij, SE; Spies, PE; Swart, LM; van der Zanden, V; van Munster, BC | 1 |
| Baker, O; Garner, C; Nelson, LS; Poon, SJ; Rodgers, AF; Schuur, JD; Weiner, SG | 1 |
| Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
| Azhar, A; Baumgartner, K; Bruera, E; Dost, S; Heung, Y; Kwan, S; Lim, KH; Liu, D; Nguyen, A; Pangemanan, I; Reddy, A; Rodriguez, E; Stephen, S; Tayjasanant, S; Vidal, M; Waletich, J; Williams, J; Wong, A; Wu, J; Yennurajalingam, S | 1 |
| Ishizuka, H; Kiyosawa, N; Toyama, K; Watanabe, K | 1 |
| He, GZ; Xu, XM; Yang, C | 1 |
| Bynum, ND; Flegel, R; Grabenauer, M; Hayes, ED; Mitchell, JM; Moore, KN; White, RM | 1 |
| Bayer, O; Heid, F; Laufenberg-Feldmann, R; Schuster, M | 1 |
| Aruga, E; Inoue, S; Saito, Y; Takahashi, H; Tsuneto, S; Uemori, M | 1 |
| Doucette, ML; Frattaroli, S; Haring, RS; Shields, WC | 1 |
| Feng, Z; Guo, J; Guo, X; Peng, Z; Zhang, Y | 1 |
| Blackney, KA; Edwards, DA; Kamdar, NV; Liu, CA | 1 |
| Brooks-Lim, E; Chan, EYL; Jones, GR; Klein, KB; McDonald, BM; Svenson, LW | 1 |
| Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S | 1 |
| Guevara, M; Hofilena, D; Mikel, C; West, R | 1 |
| Berterame, S; Bosetti, C; Corli, O; Erthal, J; Radrezza, S; Santucci, C | 1 |
| Garg, AX; Jandoc, R; Koivu, S; Silverman, M; Slater, J; Weir, MA | 1 |
| Agüera, A; Campos-Mañas, MC; Ferrer, I; Sánchez Pérez, JA; Thurman, EM | 1 |
| Brás, M; Fragoso, M; Vieira, C | 1 |
| Dani, M; Kennedy, D | 1 |
| Gomes, T; Greaves, S; Juurlink, DN; Li, P; Macdonald, EM; Mamdani, MM; Mazereeuw, G; Redelmeier, DA | 1 |
| Harings-Kaim, A; Leuppi-Taegtmeyer, A; Pfefferkorn, F; Schönenberger, M | 1 |
| Krähenbühl, S | 1 |
| Dember, LM; Jhamb, M; Liebschutz, J; Roy, PJ; Weltman, M | 1 |
| Ishiki, H; Kiuchi, D; Sato, N; Satomi, E; Shimizu, M; Yoshida, T | 1 |
| Austin, PC; Gomes, T; Juurlink, DN; Mamdani, M; Pang, A; Paterson, JM; Ray, JG; Zipursky, JS | 1 |
| Dong, S; Dou, Z; Knaggs, R; Li, Y; Lu, G; Ma, J; Xia, J; Yang, L; Zhao, S | 1 |
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Choi, SS; Kim, AR; Kim, H; Kim, YS; Lee, CH; Lee, MK; Oh, SK | 1 |
| Atayee, RS; Edmonds, KP; Wen, RY | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Chen, Y; Jiang, R; Jin, L; Mao, W; Tian, W; Xu, Z; Yu, H | 1 |
| Bateman, BT; Esposito, DB; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Straub, L; Werler, MM | 1 |
| Cassella-Mclane, G; Choucair, I; Durant, TJS; El-Khoury, JM; Vera, MA; Villalba, CF | 1 |
| Bowie, AC; Brogly, SB; Camden, A; Guttmann, A; Li, W; Velez, MP; Werler, MM | 1 |
| Hui, D; Ikari, T; Imai, K; Inoue, A; Inoue, S; Matsuda, Y; Matsumoto, Y; Matsunuma, R; Miwa, S; Mori, M; Morita, T; Okamoto, S; Satomi, E; Suzuki, K; Watanabe, H; Yamaguchi, T; Yamauchi, T; Yokomichi, N | 1 |
| Dräger, DL | 1 |
| Arakawa, S; Chiu, SW; Hiratsuka, Y; Hirayama, H; Inoue, A; Ishiki, H; Kosugi, K; Kubo, E; Matsuda, Y; Miyashita, M; Morita, T; Natsume, M; Nishijima, K; Ouchi, K; Sato, M; Satomi, E; Shigeno, T; Shimizu, M; Shimoda, M; Shimoi, T; Tagami, K; Yamaguchi, T; Yokomichi, N | 1 |
17 review(s) available for hydromorphone and oxycodone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New opioid preparations in the treatment of pain].
Topics: Administration, Cutaneous; Analgesics, Opioid; Clinical Competence; Fentanyl; Humans; Hydromorphone; Oxycodone; Pain; Pain, Intractable; Tramadol | 1999 |
Contribution to variability in response to opioids.
Topics: Analgesics, Opioid; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fentanyl; Humans; Hydromorphone; Male; Maximum Tolerated Dose; Morphine; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
The management of pain in children with life-limiting illnesses.
Topics: Analgesics, Opioid; Child; Chronic Disease; Codeine; Fentanyl; Humans; Hydromorphone; Ketamine; Methadone; Morphine; Nociceptors; Oxycodone; Pain; Pain Measurement; Severity of Illness Index | 2007 |
[Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Evidence-Based Medicine; Female; Humans; Hydromorphone; Immunity, Cellular; Male; Metabolic Clearance Rate; Middle Aged; Morphine; Oxycodone; Pain; Randomized Controlled Trials as Topic | 2008 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
[New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
Topics: Administration, Oral; Analgesics, Opioid; Analgesics, Short-Acting; Drug Administration Schedule; Drug Approval; Fentanyl; Humans; Hungary; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Therapeutic Equivalency; Time Factors | 2015 |
Hydromorphone for cancer pain.
Topics: Adult; Analgesics, Opioid; Female; Humans; Hydromorphone; Male; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Randomized Controlled Trials as Topic | 2016 |
The Comparative Risk of Delirium with Different Opioids: A Systematic Review.
Topics: Aged; Analgesics, Opioid; Delirium; Humans; Hydromorphone; Meperidine; Morphine; Oxycodone; Pain; Pain Measurement; Risk Factors; Tramadol | 2017 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Mucosal; Administration, Oral; Analgesics, Opioid; Burns; Feasibility Studies; Fentanyl; Humans; Hydromorphone; Morphine; Mouth Mucosa; Oxycodone; Pain; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Opioid Rotation in Cancer Pain Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Cancer Pain; Chronic Pain; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain Management | 2018 |
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol | 2018 |
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol | 2019 |
Hydromorphone for cancer pain.
Topics: Adult; Analgesics, Opioid; Cancer Pain; Child; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone | 2021 |
10 trial(s) available for hydromorphone and oxycodone
| Article | Year |
|---|---|
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain.
Topics: Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain | 1997 |
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Female; Hip; Humans; Hydromorphone; Knee; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain | 2007 |
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Health Status Indicators; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement | 2008 |
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Humans; Hydrocodone; Hydromorphone; Miosis; Oculomotor Muscles; Opioid-Related Disorders; Oxycodone; Prescription Drugs; Psychomotor Performance; Pupil | 2008 |
Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Pain; Drug Administration Schedule; Drug Delivery Systems; Emotions; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Measurement; Quality of Life; Sleep Wake Disorders; Time Factors; Treatment Outcome | 2013 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Arthroplasty, Replacement, Knee; Bupivacaine; Double-Blind Method; Female; Femoral Nerve; Humans; Hydromorphone; Male; Muscle Weakness; Nerve Block; Oxycodone; Pain Measurement; Pain, Postoperative; Postoperative Complications; Prospective Studies; Quadriceps Muscle; Treatment Outcome | 2014 |
Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Sample Size; Treatment Outcome; Young Adult | 2014 |
A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
Topics: Aged; Analgesics, Opioid; Asian People; Cancer Pain; Delayed-Action Preparations; Demography; Depression; Double-Blind Method; Female; Humans; Hydromorphone; Japan; Male; Neoplasms; Oxycodone; Pain Measurement; Powders; Tablets; Treatment Outcome | 2018 |
Patient-controlled intravenous analgesia with opioids after thoracoscopic lung surgery: a randomized clinical trial.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Humans; Hydromorphone; Lung; Oxycodone; Pain, Postoperative; Postoperative Nausea and Vomiting; Sufentanil | 2022 |
73 other study(ies) available for hydromorphone and oxycodone
| Article | Year |
|---|---|
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time | 1981 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Histamine release induced by opioid analgesics: a comparative study using porcine mast cells.
Topics: Analgesics, Opioid; Animals; Histamine Release; Hydromorphone; Kidney; Liver; Lung; Mast Cells; Meperidine; Methadone; Morphine; Myocardium; Oxycodone; Swine | 1991 |
Drugs in dentistry. Narcotic analgesics: the opioids.
Topics: Analgesics, Opioid; Dental Care; Humans; Hydrocodone; Hydromorphone; Oxycodone | 1987 |
Sublingual absorption of selected opioid analgesics.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Analysis of Variance; Biological Availability; Buprenorphine; Fentanyl; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Morphine; Mouth; Naloxone; Oxycodone; Time Factors | 1988 |
[Synthesis of long-acting analgesic hydrazone derivatives of 14-hydroxycodeinone and 14-hydroxymorphine].
Topics: Analgesics; Animals; Codeine; Hydromorphone; Mice; Oxycodone; Oxymorphone | 1983 |
Facilitation of thin-layer chromatographic identification of opiates by derivatization with acetic anhydride or methoxyamine.
Topics: Acetic Anhydrides; Chromatography, Thin Layer; Codeine; Humans; Hydrocodone; Hydromorphone; Hydroxylamines; Indicators and Reagents; Morphine; Morphine Derivatives; Narcotics; Oxycodone; Oxymorphone | 1995 |
Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study.
Topics: Animals; Cell Division; Codeine; Hydromorphone; Immune System; Immunosuppression Therapy; Interleukin-2; Male; Mice; Morphine; Nalorphine; Naloxone; Naltrexone; Narcotics; Oxycodone; Structure-Activity Relationship | 1997 |
Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry.
Topics: Codeine; Gas Chromatography-Mass Spectrometry; Humans; Hydrocodone; Hydromorphone; Molecular Structure; Morphine; Morphine Derivatives; Narcotics; Oxycodone; Oxymorphone | 1999 |
Trends in medical use and abuse of opioid analgesics.
Topics: Analgesics, Opioid; Drug Utilization; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Retrospective Studies; Risk Assessment; Social Change; United States | 2000 |
[Opioids. Pharmacology, clinic, prospectives for an extensive use].
Topics: Analgesics, Opioid; Codeine; Drug Tolerance; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Oxycodone; Receptors, Opioid; Tramadol | 2000 |
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Topics: Administration, Oral; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Injections, Subcutaneous; Methadone; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care | 2001 |
The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid.
Topics: Codeine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Narcotics; Oxycodone; Reproducibility of Results; Saliva; Substance Abuse Detection | 2002 |
Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dexamethasone; Drug Therapy, Combination; Humans; Hydromorphone; Ketamine; Ketorolac; Male; Middle Aged; Oxycodone; Pain; Prospective Studies | 2005 |
Decoration of the aromatic ring of dihydrocodeinone (hydrocodone) and 14-hydroxydihydrocodeinone (oxycodone).
Topics: Acids; Bromine; Hydrocodone; Hydromorphone; Iodine; Molecular Structure; Narcotics; Oxycodone | 2005 |
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Topics: Aged; Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization Review; Female; Fentanyl; Hospitals; Humans; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Palliative Care; Prospective Studies; Treatment Outcome | 2005 |
Post-dural headache associated with thoracic paravertebral blocks.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arachnoid Cysts; Brain; Cisterna Magna; Humans; Hydromorphone; Ketorolac Tromethamine; Male; Nerve Block; Oxycodone; Pain Measurement; Pain, Postoperative; Post-Dural Puncture Headache; Postoperative Complications; Postoperative Nausea and Vomiting; Sodium Chloride; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Topical lidocaine and epidural bupivacaine/hydromorphone in the treatment of complex regional pain syndrome type 2.
Topics: Administration, Topical; Adult; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Causalgia; Chondrosarcoma; Drug Combinations; Drug Synergism; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Leg; Lidocaine; Oxycodone; Pregabalin; Sacrum; Spinal Nerve Roots; Treatment Outcome | 2007 |
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Delayed-Action Preparations; Germany; Humans; Hydromorphone; Osteoarthritis; Oxycodone; Pain; Sleep; Treatment Outcome | 2007 |
An estimate of the proportion of drug-facilitation of sexual assault in four U.S. localities.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Amitriptyline; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Doxylamine; Dronabinol; Ethanol; Female; Flunitrazepam; Forensic Toxicology; Hair; Histamine H1 Antagonists; Humans; Hydromorphone; Male; Narcotics; Nortriptyline; Oxazepam; Oxycodone; Psychotropic Drugs; Sex Offenses; Substance Abuse Detection; United States | 2007 |
The underrecognized toll of prescription opioid abuse on young children.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Buprenorphine; Child, Preschool; Female; Humans; Hydrocodone; Hydromorphone; Infant; Infant, Newborn; Male; Methadone; Morphine; Oxycodone; Poisoning; Prescription Drugs; United States | 2009 |
Palliative care intervention for choice and use of opioids in the last hours of life.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Codeine; Female; Humans; Hydromorphone; Male; Meperidine; Middle Aged; Oxycodone; Palliative Care; Terminal Care | 2008 |
Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection.
Topics: Chromatography, Liquid; Codeine; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Oxycodone; Oxymorphone; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
Topics: Acetylation; Codeine; False Negative Reactions; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Hydrocodone; Hydromorphone; Immunoassay; Morphine; Opiate Alkaloids; Oxycodone; Oxymorphone; Substance Abuse Detection | 2010 |
Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
Topics: Aged; Analgesics, Opioid; Chronic Disease; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Oxycodone; Oxymorphone; Pain Measurement; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Quantitation of opioids in whole blood by electron impact-gas chromatography-mass spectrometry.
Topics: Analgesics, Opioid; Codeine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Oxycodone; Oxymorphone; Substance Abuse Detection | 2011 |
Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.
Topics: Adenosine; Amines; Analgesics; Analgesics, Opioid; Animals; Brain; Clonidine; Cyclohexanecarboxylic Acids; Disease Models, Animal; Electric Stimulation; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Hydromorphone; Injections, Spinal; Male; Methadone; Oxycodone; Peripheral Nerve Injuries; Rats; Rats, Inbred F344; Reward | 2011 |
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.
Topics: Analgesics, Opioid; Benzodiazepines; Canada; Chronic Pain; Codeine; Humans; Hydromorphone; Mass Screening; Opioid-Related Disorders; Oxycodone; Patient Education as Topic; Sleep Apnea Syndromes; Tramadol | 2011 |
Pharmacists' experiences with dispensing opioids: provincial survey.
Topics: Adult; Aged; Alcohol Drinking; Analgesics, Opioid; Chronic Pain; Codeine; Data Collection; Drug Prescriptions; Drug-Seeking Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Hydromorphone; Hypnotics and Sedatives; Interdisciplinary Communication; Interprofessional Relations; Male; Medication Adherence; Middle Aged; Ontario; Oxycodone; Pharmacists; Practice Patterns, Physicians' | 2011 |
Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Hydrocodone; Hydromorphone; Hydrophobic and Hydrophilic Interactions; Oxycodone; Oxymorphone; Reproducibility of Results; Tandem Mass Spectrometry | 2011 |
[Prescription of high-potency opioids in 2011].
Topics: Administration, Cutaneous; Analgesics, Opioid; Drug Therapy, Combination; Drug Utilization; Fentanyl; Germany; Humans; Hydromorphone; Morphine; Oxycodone; Practice Patterns, Physicians' | 2012 |
[Oral therapy algorithm for the treatment of postoperative pain. A prospective observational study].
Topics: Administration, Oral; Adult; Algorithms; Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Feasibility Studies; Female; Germany; Humans; Hydromorphone; Male; Middle Aged; Otorhinolaryngologic Surgical Procedures; Oxycodone; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Preoperative Care; Prospective Studies; Wounds and Injuries | 2013 |
Multimodal analgesia therapy reduces length of hospitalization in patients undergoing fusions of the ankle and hindfoot.
Topics: Acetaminophen; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Anesthesia, General; Anesthesia, Spinal; Ankle Joint; Anti-Inflammatory Agents; Arthrodesis; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Morphine; Oxycodone; Pain Management; Pain, Postoperative; Postoperative Care; Prednisone; Pregabalin; Preoperative Care; Pyrazoles; Retrospective Studies; Subtalar Joint; Sulfonamides | 2013 |
Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Emergency Service, Hospital; Female; Health Care Surveys; Humans; Hydrocodone; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Pain Measurement; Patient Discharge; Practice Patterns, Physicians'; United States | 2014 |
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuse.
Topics: Acetaminophen; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Combinations; Humans; Hydrocodone; Hydromorphone; Internet; Opioid-Related Disorders; Oxycodone; Social Media | 2014 |
A microbial biomanufacturing platform for natural and semisynthetic opioids.
Topics: Bacterial Proteins; Codeine; Gene Dosage; Gene Expression; Hydrocodone; Hydromorphone; Metabolic Engineering; Metabolic Networks and Pathways; Morphine; Oxycodone; Papaver; Plant Proteins; Pseudomonas putida; Saccharomyces cerevisiae; Thebaine | 2014 |
Multi-drug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Cocaine; Codeine; Dextromethorphan; Diphenhydramine; Evaluation Studies as Topic; Forensic Pathology; Humans; Hydrocodone; Hydromorphone; Meperidine; Methadone; Morphine; Oxycodone; Oxymorphone; Pyrrolidines; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
Opiate refractory pain from an intestinal obstruction responsive to an intravenous lidocaine infusion.
Topics: Abdominal Pain; Analgesics, Opioid; Anesthetics, Local; Antiemetics; Colostomy; Diagnosis, Differential; Emergency Service, Hospital; Female; Humans; Hydromorphone; Infusions, Intravenous; Intestinal Obstruction; Lidocaine; Metoclopramide; Oxycodone; Tomography, X-Ray Computed; Young Adult | 2015 |
LC-MS-MS Method for Analysis of Opiates in Wastewater During Football Games II.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Football; Humans; Hydrocodone; Hydromorphone; Morphine; Opiate Alkaloids; Oxycodone; Oxymorphone; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2016 |
Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Cytochrome P-450 CYP2D6; Glucuronidase; Humans; Hydrocodone; Hydrolysis; Hydromorphone; Morphine; Morphine Derivatives; Opiate Alkaloids; Oxycodone; Oxymorphone; Specimen Handling; Tandem Mass Spectrometry | 2016 |
Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis.
Topics: Analgesics, Opioid; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Immunoassay; Oxycodone; Oxymorphone; Sensitivity and Specificity; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Patients at Risk: Large Opioid Prescriptions After Total Knee Arthroplasty.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Drug Combinations; Drug Prescriptions; Female; Follow-Up Studies; Humans; Hydrocodone; Hydromorphone; Knee Joint; Male; Middle Aged; Morphine; Opioid-Related Disorders; Oxycodone; Pain, Postoperative; Patient Discharge; Reoperation; Retrospective Studies | 2017 |
The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
Topics: Adult; Analgesics, Opioid; Codeine; Emergency Service, Hospital; Female; Guideline Adherence; Humans; Hydrocodone; Hydromorphone; Male; Middle Aged; Ohio; Oxycodone; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tramadol | 2017 |
The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Drug Dosage Calculations; Female; Humans; Hydromorphone; Linear Models; Male; Middle Aged; Morphine; Oxycodone; Palliative Care; Patient Discharge; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
Topics: Adult; Analgesics, Opioid; Biomarkers; Humans; Hydromorphone; Male; MicroRNAs; Oxycodone; Receptors, Opioid, mu | 2017 |
Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
Topics: Analgesics, Opioid; Calibration; Chromatography, Liquid; Codeine; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Opioid-Related Disorders; Oxycodone; Oxymorphone; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Saliva; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |
Storing and Disposing of Opioid Analgesics: What Does Our Medicine Tell Us?
Topics: Analgesics, Opioid; Drug Labeling; Drug Storage; Fentanyl; Humans; Hydrocodone; Hydromorphone; Medical Waste Disposal; Morphine; Oxycodone; Prescription Drug Diversion; Safety; Tramadol | 2018 |
Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Female; Humans; Hydromorphone; Male; Middle Aged; Oxycodone; Pain Management; Patient Satisfaction; Retrospective Studies; Sufentanil | 2018 |
Methylnaltrexone-Associated Bowel Perforation in Postoperative Opioid-Induced Constipation and Ogilvie Syndrome: A Case Report.
Topics: Analgesics, Opioid; Colonic Pseudo-Obstruction; Constipation; Decompression, Surgical; Humans; Hydromorphone; Intestinal Perforation; Low Back Pain; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Postoperative Complications; Quaternary Ammonium Compounds; Spinal Stenosis | 2019 |
At-a-glance - The role of opioid toxicity in suicide deaths in Alberta, 2000 to 2016.
Topics: Adult; Age Factors; Alberta; Analgesics, Opioid; Codeine; Female; Humans; Hydromorphone; International Classification of Diseases; Male; Middle Aged; Morphine; Oxycodone; Sex Factors; Suicide; Vital Statistics | 2018 |
Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.
Topics: Buprenorphine; Cannabinoids; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Illicit Drugs; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Oxymorphone; Retrospective Studies; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |
Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016.
Topics: Analgesics, Opioid; Europe; European Union; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Oxycodone; Pain; Practice Patterns, Physicians'; Regression Analysis; United States | 2019 |
The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.
Topics: Adult; Analgesics, Opioid; Drug Prescriptions; Drug Utilization; Endocarditis; Female; Humans; Hydromorphone; Interrupted Time Series Analysis; Male; Middle Aged; Ontario; Oxycodone; Patient Admission; Population Surveillance; Retrospective Studies; Substance Abuse, Intravenous; Young Adult | 2019 |
Identification of opioids in surface and wastewaters by LC/QTOF-MS using retrospective data analysis.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Data Analysis; Environmental Monitoring; Fentanyl; Heroin; Hydrocodone; Hydromorphone; Minnesota; Morphine; Morphine Derivatives; Oxycodone; Retrospective Studies; Substance Abuse Detection; Tandem Mass Spectrometry; Tramadol; Wastewater; Water Pollutants, Chemical | 2019 |
Comparative Analysis of ELISA Immunoassay and LC-QTOF for Opiate Screening.
Topics: Analgesics, Opioid; Chromatography, Liquid; Codeine; Enzyme-Linked Immunosorbent Assay; Humans; Hydrocodone; Hydromorphone; Morphine; Morphine Derivatives; Oxycodone; Oxymorphone; Substance Abuse Detection | 2020 |
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case-Control Study.
Topics: Adult; Analgesics, Opioid; Case-Control Studies; Drug Overdose; Female; Humans; Hydromorphone; Male; Mental Disorders; Middle Aged; Ontario; Oxycodone; Population; Retrospective Studies; Suicide | 2020 |
[Opioids in patients with renal impairment].
Topics: Analgesics, Opioid; Fentanyl; Humans; Hydromorphone; Oxycodone; Tramadol | 2020 |
[Opioid therapy in patients with liver cirrhosis].
Topics: Analgesics, Opioid; Humans; Hydromorphone; Liver Cirrhosis; Oxycodone; Switzerland | 2020 |
Pain management in patients with chronic kidney disease and end-stage kidney disease.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Kidney Failure, Chronic; Oxycodone; Pain; Pain Management; Receptors, Opioid, mu; Renal Insufficiency, Chronic | 2020 |
[Hydromorphone in Cancer Patients-A Retrospective Study].
Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Oxycodone; Retrospective Studies | 2020 |
Trends in Postpartum Opioid Prescribing: A Time Series Analysis.
Topics: Adult; Analgesics, Opioid; Breast Feeding; Codeine; Female; Humans; Hydromorphone; Infant, Newborn; Interrupted Time Series Analysis; Lactation; Morphine; Ontario; Oxycodone; Postpartum Period; Practice Patterns, Physicians'; Pregnancy; Young Adult | 2021 |
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
Microbiological and Physicochemical Stability of Fentanyl, Oxycodone, Hydromorphone, Ketorolac, Ramosetron, and Ondansetron for Intravenous Patient-controlled Analgesia: An In Vitro Study.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Benzimidazoles; Fentanyl; Humans; Hydromorphone; Ketorolac; Ondansetron; Oxycodone; Pain, Postoperative | 2021 |
A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.
Topics: Administration, Oral; Analgesics, Opioid; Fentanyl; Humans; Hydrocodone; Hydromorphone; Levorphanol; Morphine; Oxycodone; Tapentadol; Tramadol | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Topics: Adult; Analgesics, Opioid; Codeine; Cohort Studies; Female; Humans; Hydrocodone; Hydromorphone; Infant, Newborn; Infant, Newborn, Diseases; Methadone; Morphine; Neonatal Abstinence Syndrome; Oxycodone; Pain; Pregnancy; Prescriptions; Substance Withdrawal Syndrome; Tramadol; United States | 2022 |
A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use.
Topics: Analgesics, Opioid; Chromatography, Liquid; Humans; Hydrocodone; Hydromorphone; Opioid-Related Disorders; Oxycodone; Oxymorphone; Tandem Mass Spectrometry | 2023 |
Safety of prenatal opioid analgesics: Do results differ between public health insurance beneficiary and population-based cohorts?
Topics: Analgesics, Opioid; Codeine; Female; Humans; Hydromorphone; Insurance Benefits; Oxycodone; Pregnancy; Public Health | 2023 |
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study.
Topics: Aged; Analgesics, Opioid; Cohort Studies; Dyspnea; Humans; Hydromorphone; Morphine; Neoplasms; Oxycodone | 2023 |
[Drug therapy for cancer-related pain-evidence regarding hydromorphone, oxycodone, and methadone : Presentation and summary of three Cochrane reviews].
Topics: Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Methadone; Neoplasms; Oxycodone | 2023 |
Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study.
Topics: Analgesics, Opioid; Cancer Pain; Constipation; Delirium; Fentanyl; Humans; Hydromorphone; Japan; Longitudinal Studies; Nausea; Oxycodone; Prevalence; Prospective Studies; Tramadol; Vomiting | 2023 |